Medpace Holdings, Inc. (MEDP) — Financial statements
Income statement, balance sheet, and cash flow for Medpace Holdings, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,530↑20.0% | 2,109↑11.8% | 1,886↑29.2% | 1,460↑27.8% | 1,142 | |
| Cost of Revenue | 1,770↑21.8% | 1,453↑6.7% | 1,361↑32.5% | 1,028↑26.2% | 814 | |
| Gross Profit | 761↑15.9% | 656↑25.1% | 525↑21.3% | 432↑31.8% | 328 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 179 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 2 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 198↑9.6% | 180↑11.7% | 161↑22.8% | 131↑21.2% | 108 | |
| Other Expenses | 28↓3.9% | 29↑11.1% | 26↑17.8% | 22↑5.8% | 21 | |
| Operating Expenses | 226↑7.8% | 209↑11.6% | 188↑22.1% | 154↑18.7% | 130 | |
| Total Costs & Expenses | 1,995↑20.0% | 1,662↑7.3% | 1,549↑31.1% | 1,181↑25.2% | 944 | |
| Operating Results | ||||||
| Operating Income | 535↑19.7% | 447↑32.7% | 337↑20.9% | 279↑40.3% | 199 | |
| Depreciation & Amortization | 28↓3.9% | 29↑11.1% | 26↑17.8% | 22↑5.8% | 21 | |
| EBITDA | 571↑19.8% | 476↑31.1% | 363↑20.6% | 301↑37.0% | 220 | |
| EBIT | 542↑21.4% | 447↑32.7% | 337↑20.9% | 279↑40.3% | 199 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 25↑5222.1% | -0.49↑83.2% | -3↓2666.7% | -0.11 | |
| Interest Income | 0.00↓100.0% | 25 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 0.49↓83.2% | 3↑2666.7% | 0.11 | |
| Non-Operating Income | -7 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 7↓74.4% | 29↑2641.7% | -1↓127.5% | 4↑28.6% | 3 | |
| Income Before Tax | 542↑14.0% | 476↑41.8% | 336↑18.7% | 283↑40.1% | 202 | |
| Income Tax Expense | 91↑27.6% | 72↑35.3% | 53↑41.0% | 37↑87.4% | 20 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 451↑11.6% | 404↑43.0% | 283↑15.3% | 245↑34.9% | 182 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 451↑11.6% | 404↑43.0% | 283↑15.3% | 245↑34.9% | 182 | |
| Bottom-Line Net Income | 451↑11.6% | 404↑43.1% | 283↑15.3% | 245↑35.2% | 181 | |
| EPS (Basic) | 15.64↑19.8% | 13.06↑42.0% | 9.20↑21.5% | 7.57↑49.6% | 5.06 | |
| EPS (Diluted) | 15.28↑21.0% | 12.63↑42.2% | 8.88↑22.0% | 7.28↑51.4% | 4.81 | |
| Weighted Average Shares | 29↓6.8% | 31↑0.8% | 31↓5.1% | 32↓9.7% | 36 | |
| Weighted Average Diluted Shares | 30↓7.8% | 32↑0.5% | 32↓5.4% | 34↓10.7% | 38 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.